Kaken Pharmaceutical Co., Ltd. (4521.T) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Kaken Pharmaceutical Co., Ltd., with annual and quarterly history.
| Metric | 2026 |
|---|---|
| Valuation | |
| P/E Ratio | 73.21x |
| P/B Ratio | 1.06x |
| P/S Ratio | 2.04x |
| Profitability | |
| Gross Margin | 51.0% |
| Operating Margin | -1.2% |
| Net Margin | 2.8% |
| EBITDA Margin | 7.4% |
| Liquidity | |
| Current Ratio | 4.52x |
| Quick Ratio | 3.60x |
| Leverage | |
| Debt/Equity | 0.03x |
YoY = year-over-year change. Source: FMP..